Email alerts
Advanced Search
  • May 8, 2012
    Medtronic Expands Availability of Valiant(R) Captivia(R) Stent Graft in Major Global Markets
    Implantable Medical Device for Endovascular Repair of Thoracic Aortic Aneurysms Also Being Studied for Minimally Invasive Treatment of Blunt Thoracic Aortic Injuries

    MINNEAPOLIS--(BUSINESS WIRE)--May. 8, 2012-- Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. (NYSE: MDT) is expanding availability of the Valiant®...

  • Apr 30, 2012
    Eighteen North Suburban High School Graduates Named 2012 Medtronic Scholars
    Medtronic Foundation has committed nearly $1.5 million in local scholarships.

    MINNEAPOLIS--(BUSINESS WIRE)--Apr. 30, 2012-- The Medtronic Foundation today announced that 18 students have been selected as 2012 Medtronic Scholars. Each will receive a four-year scholarship...

  • Apr 27, 2012
    Trial of Medtronic Symplicity(TM) Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment
    Six Month Pooled Outcomes From Randomized and Crossover Patients Following Renal Denervation Presented at the 22nd Annual Scientific Meeting of the European Society of Hypertension Confirm Previous Symplicity Clinical Trial Findings

    MINNEAPOLIS & LONDON, Apr 27, 2012 (BUSINESS WIRE) --Medtronic, Inc., (NYSE: MDT), announced today six month pooled outcomes from randomized and crossover patients in the Symplicity HTN-2 clinical...

  • Apr 24, 2012
    Medtronic Named One of America's Best Corporate Citizens
    Medical Technology Leader Ranked in Top 50 on Corporate Responsibility Magazine's 100 Best Corporate Citizens List

    MINNEAPOLIS, Apr 24, 2012 (BUSINESS WIRE) --Medtronic, Inc. is one of America's best corporate citizens, according to the rankings recently released by Corporate Responsibility magazine. Medtronic...

  • Apr 17, 2012
    Medtronic Announces Global Drug-Eluting Balloon Study
    International Research Program Will Collect and Assess Safety and Efficacy Data on IN.PACT Admiral(TM) Drug-Eluting Balloon in Treatment of Peripheral Artery Disease

    MINNEAPOLIS & LONDON, Apr 17, 2012 (BUSINESS WIRE) --In conjunction with the Charing Cross International Symposium (CX34), which concludes today in London, Minneapolis-based Medtronic, Inc. (NYSE:...

Show 5102550100 per page